About Us

Who We Are

We are committed to advancing exosome-based therapeutics that are both safe and effective, offering new hope for patients with intractable diseases.
We are setting a new standard for exosome therapeutics.

Leadership
  • Oh Young Bang
    CEO, Founder, MD, PhD

    Professor of Neurology
    Samsung Medical Center
    & Sungkyunkwan University

  • Seung Woo Yeon
    CSO, PhD

    20+ years of
    new drug development
    at Ildong Pharmaceutical

  • Jae Bok Ban
    COO, MS

    20+ years of experience
    in biotech commercialization
    at KoreaBIO

  • Eun Hee Kim
    CTO, PhD

    20+ years of expertise
    in stem cell and miRNA
    research

History
2025
  • 04 SNE-101S Phase 1b IND approved by MFDS (Korea)
2024
  • 10 Patent granted for EV lyophilization protectant (Korea)
  • 04 Selected for Bio & Medical Technology Development Program (Korea)
  • 01 Patent granted for 3D EV angiogenesis-promoting composition (Korea)
  • 01 Patent granted for 3D EV neuroregenerative composition (Korea)
  • 01 Patent granted for EV wound-healing composition (Korea)
2023
  • 09 Selected for Bio-Medical Technology Commercialization Program (Korea)
  • 09 Patent granted for 3D EV manufacturing method (Korea, Japan)
  • 03 Series A funding secured
2022
  • 11 Series A funding secured
  • 06 Licensed-in patent for enhanced EV efficacy method (granted in Korea, USA)
  • 04 Selected for Innovation Startup Package (Korea)
  • 04 Selected for Regenerative Medicine R&D Program (Korea)
2021
  • 06 Selected for Materials & Components R&D Program (Korea)
  • 01 Relocated and expanded Research Institute
2020
  • 12 Series Pre-A funding secured
  • 11 Selected for Early Startup Package Program (Korea)
  • 07 Selected for Startup Growth Technology Development Program (Korea)
  • 07 Selected for Promising Startup Growth Package (Korea)
  • 05 Licensed-in patent for EV therapeutic production method (granted in Korea, USA)
  • 04 Certified as a Venture Enterprise
  • 02 Series Pre-A funding secured
  • 01 Affiliated Research Institute certified by KOITA (Korea)
2019
  • 05 Licensed-in patent for EV therapeutic composition (granted in Korea, USA, Europe, Japan)
  • 01 S&E bio Co., Ltd. founded